🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

672 results for “Nan” Clear

  1. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial

  2. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  3. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  4. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre Fabre Australia Pty Ltd

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  5. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  6. Initiating daily oral PrEP during pregnancy

    United Therapeutics Europe Ltd

    Pre-exposure Prophylaxis

    approved small molecule active

    1 trial

  7. Isotonic hydration fluid and recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  8. Mifepristone

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy Related

    approved small molecule completed

    1 trial

  9. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial

  10. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  11. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  12. Pertussis containing vaccine

    United Therapeutics Europe Ltd

    Pregnancy Related

    approved mab active

    1 trial

  13. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  14. Prilocaine (Hyperbaric 2%)

    United Therapeutics Europe Ltd

    Cervical Incompetence in Pregnancy as Antepartum Condition

    approved small molecule active

    1 trial

  15. Recombinant FSH (follitropin alpha)

    United Therapeutics Europe Ltd

    Ovulation Induction

    approved small molecule completed

    1 trial

  16. Recombinant Human Adenovirus Type 5 injection

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma

    approved small molecule active

    1 trial

  17. Recombinant Protein-Free Factor VIII (rAHF-PFM)

    Takeda

    Hemophilia A

    approved small molecule completed

    1 trial

  18. Recombinant Staphylokinase

    The First People's Hospital of Lianyungang

    ST-segment Elevation Myocardial Infarction (STEMI)

    approved small molecule completed

    1 trial

  19. Recombinant Staphylokinase

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule completed

    1 trial

  20. Recombinant human growth hormone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Achondroplasia

    approved small molecule active

    1 trial

  21. Recombinant human growth hormone (r-hGH)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Dwarfism, Pituitary

    approved small molecule completed

    1 trial

  22. Recombinant staphylokinase

    The First People's Hospital of Lianyungang

    ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  23. Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)

    United Therapeutics Europe Ltd

    Diarrhea

    approved mab active

    1 trial

  24. Recombinant tissue plasminogen activator (rt-PA)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Thromboembolisms

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources